동의생리병리학회지 (Journal of Physiology & Pathology in Korean Medicine)

  • 제37권6호
  • /
  • Pages.178-184
  • /
  • 2023
  • /
  • 1738-7698(pISSN)
  • /
  • 2288-2529(eISSN)
대한동의생리학회·한의병리학회 ( The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

'표준치료를 받은 폐암 환자의 한방병원 입원 임상경로' 개발 및 적용

Developed and Implemented a Clinical Pathway for Lung Cancer Patients Admitted to Korean Medicine Hospital after Standard Treatment

  • 고금영 (부산대학교 건강노화 한의과학 연구센터) ;
  • 박소정 (부산대학교 한의학전문대학원 한의학과) ;
  • 김동현 (대전대학교 한의과대학) ;
  • 하기태 (부산대학교 건강노화 한의과학 연구센터) ;
  • 유화승 (대전대학교 한의과대학) ;
  • 윤성훈 (양산부산대학교병원 호흡기내과) ;
  • 최준용 (부산대학교 한의학전문대학원 한의학과)
  • Kum-Young Ko (Healthy Aging Korean Medical Research Center, Pusan National University) ;
  • So-jung Park (Department of Korean Medicine, School of Korean Medicine, Pusan National University) ;
  • Dong Hyeon Kim (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • Ki Tae Ha (Healthy Aging Korean Medical Research Center, Pusan National University) ;
  • Hwa Seung Yoo (Department of Korean Medicine, School of Korean Medicine, Daejeon National University) ;
  • Seong-Hoon Yoon (Pulmonary Medicine Center, Pusan National University YangSan Hospital) ;
  • Jun-Yong Choi (Department of Korean Medicine, School of Korean Medicine, Pusan National University)
  • 투고 : 2023.09.04
  • 심사 : 2023.10.19
  • 발행 : 2023.12.25
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The objective of this study was to develop a critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received standard western medicine treatments. A total of 10 medical professionals, including western and Korean medicine doctors, and nurses participated in a validation survey and revised clinical pathway. Then we applied the critical pathway to 11 lung cancer patients who admitted at Korean medicine hospital and evaluated quality of life at the beginning and discharge of admission using European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire(EORTC QLQ). More than 80% of the respondents gave a score of 3 (appropriate) or more for all items in the validation survey and we modified the clinical pathway by adding 'bed rest'to the activity item. When applying the revised critical pathway to 11 lung cancer patients, the score of 'Nausea and vomiting', 'Insomnia' in EORTC QLQ-30 and 'chest pain'in EORTC LC-13 showed statistically significant improvements in the before-and-after admission comparision. The application of revised inpatient critical pathway of integrative medicine for lung cancer showed improvement in some symptoms. Development of more critical pathway in various clinical setting and larger scaled application studies of critical pathway are needed.

키워드

과제정보

본 연구는 한국보건산업진흥원 한의기반융합기술개발 사업의 폐암 대규모 융합 임상연구 수행 및 협진 진료지침개발 과제(과제번호 : HI19C1046)와 한의약혁신기술개발 사업의 폐암 한의통함암치료의 한의임상진료지침 및 한의표준임상경로개발 과제(과제번호 : HF20C0093) 및 2022년도 부산대학교병원 임상연구비 지원으로 이루어졌습니다.

참고문헌

  1. Annual report of cancer statistics in Korea in 2020. National Cancer Center. 2023, p.21. Korean Statistical Information Service https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B34E01&conn_path=I2).
  2. Jang SH. Korean National Lung Cancer Screening. Korean J Med. 2020;95(2):95-103. https://doi.org/10.3904/kjm.2020.95.2.95
  3. Kim SD, Lee BH. Evaluation of Radon Exhalation Rate from Concrete Surface with Paint. J Architectural institute of Korea. 2023;43(1):849.
  4. Jung HJ, Han DH. Effects of Particulate Matter on Allergic Rhinitis and Possible Mechanisms. Korean J Otorhinolaryngol-Head Neck Surg. 2023;66(2):75-84. https://doi.org/10.3342/kjorl-hns.2022.01270
  5. Kim JS, Kang EJ. Targeted Therap for Non-Small Cell Lung Cancer. Korean J Med. 2020;95(2):78-88. https://doi.org/10.3904/kjm.2020.95.2.78
  6. Win T, Sharples L Wells FC, Ritchie AJ, Munday H, Laroche CM. Effect of lung cancer surgery on quality of life. Thorax. 2005;60(3):234-8. https://doi.org/10.1136/thx.2004.031872
  7. Korean Association for Lung Cancer. Ask me anything about lung cancer. YD&P(Seoul). 2001. p.106.
  8. Jeng HC. Principles of cancer drug therapy and managing common side effects. Korean J Med. Autumn Conference Proceedings. 2014;(2):119-28.
  9. Chang YS, Choi CM, Lee JC. Mechanisms of epidermal growth factor receptor tyrosine kinase inhibitor resistance and strategies to overcome resistance in lung adenocarcinoma. Tuberc Respir Dis (Seoul). 2016;79:248-56. https://doi.org/10.4046/trd.2016.79.4.248
  10. Jang SH. Adeverse Events of Immune Checkpoint Inhibitors. Pharmacoepidemiology and Risk Management. 2019;11(1):15-20.
  11. In-Ohg Oh, Tae-Ik Chang, Hyun-Jin Kim, Status of the Development and Utilization of Critical Pathways. Quality Improvement in Health Care. 2022;28(1):2-13. https://doi.org/10.14371/QIH.2022.28.1.2
  12. Konishi T, Noye T, Furujima K, Harihara Y. Significance of critical path for gastric cancer: Gastrointestinal diseases and social medicine. Nippon Shokakibyo Gakkai Zasshi, 2001;98(12):1341-8.
  13. Hong MN, Shim SH, Yoon SH, Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy. J Int Korean Med. 2017;38(6):917-29. https://doi.org/10.22246/jikm.2017.38.6.917
  14. Kwon HK, Kim JS, Yu HS. Review for the Status of Cancer Complementary and Alternative Medicine in the World. J Korean Tradit Oncol. 2009;14(1):1-11.
  15. Menzies AM, Johnson DB, Ramanujam S, Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Ann Oncol. 2017;28:368-76. https://doi.org/10.1093/annonc/mdw443
  16. Jung HJ, Kim JD. The role of Korean Medicine for Treatment and Management for Lung cancer. J Kor Tradit Oncol. 2015;20(1);45-54. https://doi.org/10.15432/JKTO.2015.20.1.045
  17. Yoo SH, Yoo HS, Cho CK, Lee YW. A Case Report for Recurred Squeamous Cell Lung Carcinoma Treated with Hang-An-Dan : 7-year follow-up. Korean J Int Korean Med. 2007;28(2):385-90.
  18. Zheng HM, Yoon JW, Lee YW, Cho CK, Oh DS, Yoo HS. Case Series of Advanced Non-Small Cell Lung Cancer Patients Treated with Hang-Am Plus. J Int Korean Med. 2011;32(1):113-20.
  19. Song SY, Park JH, Park SJ, Kang IC, Yoo HS. Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer. Integr Cancer Ther. 2022;21:15347354221144311.
  20. Li YX, Zhang XG, Hu SH, et al. Current Status and Prospects of TCM Maintenance Therapy in Treating Advanced NSCLC. Information on TCM. 2020;37(4):126-9.
  21. Kim MH, Kang PS, Lee KS, Utilization of Complementary and Alternative Medicine of Cancer Patient in Korea. J Agr Med Community Health 2007;32(3):155-67. https://doi.org/10.5393/JAMCH.2007.32.3.155
  22. Chang SB, Lee TW, Kim S, A study of complementary and alternative medicine used by cancer patients in Korea. J Korean Acad Adult Nurs. 2006:92-101.
  23. Wu FK. Determinants of Complementary and Alternative Medicine use among Lung Cancer patients in Shandong Province. China. Master dissertation. Hanyang University. 2023.
  24. Jeong GS. Experiences and attitudes of lung cancer patients receiving complementary and alternative therapies. Master dissertation. Kosin University graduate school. 2006.
  25. Iwase S, Yamaguchi T, Miyaji T, Terawaki K, Inui A, Uezono Y. The clinical use of Kampomedicines (traditional Japanese herbal treatments)for controlling cancer patients' symptoms in Japan: a national cross-sectional survey. BMC Complement Altern Med. 2012;12:222.
  26. Kim DH, Jeon DS, Park SC, Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients-A single group before-and-after. preliminary study. Journal of physiology & pathology in Korean Medicine. 2014;28(1):82-8. https://doi.org/10.15188/kjopp.2014.02.28.1.82
  27. Seong YS, Cho EY, Lee YS, Yang HL, Lee HJ. Effects of Nei-Guan Acupressure on Chemotherapyrelated Nausea, Vomiting. and Anorexia in Patients with Lung Cancer. Journal of East-West Nursing Research. 2010;16(1):1-10. https://doi.org/10.14370/JEWNR.2010.16.1.001
  28. Wang YL, Li JX, Guo XQ, et al.. Effect of acupuncture in different time on nausea and vomiting induced by chemotherapy of lung cancer. Zhongguo Zhen jiu. 2019;39(12):1269-73.
  29. Jang SY, Park JS. The Meta-Analysis of the Effect of Acupressure for Nausea and Vomiting in Cancer Patients Receiving Chemotherapy. J Korean Oncal Nurs. 2011;11(2):116-26. https://doi.org/10.5388/jkon.2011.11.2.116
  30. Romero SAD, Jiang E, Bussell J, What makes one respond to acupuncture for insomnia Perspectives of cancer survivors. Palliat Support Care. 2020;18(3):301-6. https://doi.org/10.1017/S1478951519000762
  31. Ye T. Observation on the application effect of acupressure care in patients with insomnia undergoing chemotherapy for lung cancer. Proceedings of 2019 Shanghai International Nursing Conference. 2019. p.790.
  32. Li J, Tang DX, Yang Z, The effect of Supplementing Qi and nourishing Yin combined with chemotherapy for lung cancer : a meta-analysis. TMR Integrative Medicine, 2018;1(2):45-54. https://doi.org/10.53388/TMRIM201701116